Media coverage about Castlight Health (NYSE:CSLT) has been trending somewhat positive on Wednesday, according to Accern Sentiment. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Castlight Health earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media headlines about the software maker an impact score of 46.4723062885984 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Several equities analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Castlight Health from a “buy” rating to a “hold” rating in a report on Monday, January 1st. BidaskClub downgraded shares of Castlight Health from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th. Canaccord Genuity restated a “buy” rating and set a $7.00 target price on shares of Castlight Health in a report on Thursday, October 26th. Chardan Capital dropped their target price on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a report on Thursday, October 26th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $5.00 target price on shares of Castlight Health in a report on Wednesday, October 25th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. Castlight Health has a consensus rating of “Hold” and a consensus target price of $5.22.
Shares of Castlight Health (CSLT) traded down $0.10 during midday trading on Wednesday, hitting $4.20. 613,200 shares of the stock were exchanged, compared to its average volume of 328,350. The stock has a market capitalization of $551.67, a P/E ratio of -8.94 and a beta of 1.66. Castlight Health has a 1-year low of $3.05 and a 1-year high of $4.75. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03.
In related news, CFO Mangini Siobhan Nolan sold 8,866 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $3.70, for a total value of $32,804.20. Following the completion of the sale, the chief financial officer now directly owns 78,561 shares in the company, valued at $290,675.70. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO John C. Doyle sold 13,686 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now owns 123,705 shares of the company’s stock, valued at $458,945.55. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,778 shares of company stock valued at $84,411. Insiders own 24.38% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2018/01/17/castlight-health-cslt-receives-coverage-optimism-rating-of-0-16.html.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.